Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
71
AUTL Quote, Financials, Valuation and Earnings
Last price:
$1.68
Seasonality move
:
-15.6%
Day range:
$1.61 - $1.79
52-week range:
$1.11 - $2.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.54x
P/B ratio:
2.20x
Volume:
3.1M
Avg. volume:
3.5M
1-year change:
-24.45%
Market cap:
$437.8M
Revenue:
$10.1M
EPS (TTM):
-$0.84
Earnings Data
Next earnings date for AUTL
Mar 19
2026
Most recent earnings per share
-$0.30
Missed by $0.07
(Nov 12/2025)
Consensus Estimate
-$0.23
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AUTL Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/19/2026 | Q4 | $24.3M | -- | -- | -$0.40 | -- |
| 11/12/2025 | Q3 | $21.3M | $21.1M | -$0.30 | -$0.23 | -$0.07 |
| 08/12/2025 | Q2 | $12.9M | $21.2M | -$0.18 | -$0.23 | $0.05 |
| 05/15/2025 | Q1 | $2M | $9M | -$0.26 | -$0.25 | -$0.01 |
| 03/20/2025 | Q4 | $3M | $28.7K | -$0.10 | -$0.24 | $0.14 |
| 11/12/2024 | Q3 | $155K | -- | -$0.31 | -$0.22 | -$0.09 |
| 08/08/2024 | Q2 | $62.5K | -- | -$0.22 | -$0.21 | -$0.01 |
| 05/14/2024 | Q1 | $25M | $10.1M | -$0.24 | -$0.14 | -$0.10 |
| 03/14/2024 | Q4 | $256K | -- | -$0.45 | -$0.26 | -$0.19 |
| 11/02/2023 | Q3 | -- | -- | -$0.26 | -$0.25 | -$0.01 |
| 08/03/2023 | Q2 | -- | -- | -$0.26 | -$0.22 | -$0.04 |
| 05/04/2023 | Q1 | -- | -- | -$0.23 | -$0.27 | $0.04 |
| 03/07/2023 | Q4 | -- | -- | -$0.23 | -$0.28 | $0.05 |
| 11/03/2022 | Q3 | -- | -- | -$0.47 | -$0.46 | -$0.01 |
| 08/04/2022 | Q2 | -- | -- | -$0.46 | -$0.33 | -$0.13 |
| 05/05/2022 | Q1 | -- | -- | -$0.41 | -$0.49 | $0.08 |
| 03/10/2022 | Q4 | -- | -- | -$0.51 | -$0.36 | -$0.15 |
| 11/03/2021 | Q3 | -- | -- | -$0.47 | -$0.51 | $0.04 |
| 08/05/2021 | Q2 | -- | -- | -$0.47 | -$0.49 | $0.02 |
| 05/06/2021 | Q1 | -- | -- | -$0.53 | -$0.59 | $0.06 |
| 03/04/2021 | Q4 | -- | -- | -$0.83 | -$0.77 | -$0.06 |
| 11/05/2020 | Q3 | -- | -- | -$0.72 | -$0.71 | -$0.01 |
| 08/06/2020 | Q2 | -- | -- | -$0.62 | -$0.70 | $0.08 |
| 05/07/2020 | Q1 | -- | -- | -$0.60 | -$0.75 | $0.15 |
| 03/03/2020 | Q4 | -- | -- | -$0.93 | -$0.74 | -$0.19 |
| 11/07/2019 | Q3 | -- | -- | -$0.61 | -$0.83 | $0.22 |
| 08/08/2019 | Q2 | -- | -- | -$0.65 | -$0.66 | $0.01 |
| 05/14/2019 | Q1 | -- | -- | -$0.69 | -$0.56 | -$0.13 |
| 02/25/2019 | Q4 | -- | -- | -$0.52 | -$0.54 | $0.02 |
| 03/31/2018 | Q1 | -- | -- | -- | -$1.64 | -- |
Autolus Therapeutics Plc Earnings Questions
-
How Much did Autolus Therapeutics Plc Generate in Revenue Last Quarter?
Autolus Therapeutics Plc reported $21.1M worth of top line sales in its most recent quarter.
-
Did Autolus Therapeutics Plc Beat Earnings Last Quarter?
Autolus Therapeutics Plc announced earnings per share of -$0.30 which represents a miss of analyst forecast a -$0.23 per share.
-
Is Autolus Therapeutics Plc Profitable?
Autolus Therapeutics Plc reported -$10.8M that represents -$0.04 per share over the last quarter.
-
What is the Analyst Consensus for Autolus Therapeutics Plc EPS Next Year?
Autolus Therapeutics Plc's earnings are forecast to decrease from -$0.87 per share to -$0.91 per share next year representing a decrease of -11.16%.
-
When is Autolus Therapeutics Plc's Earnings Date?
Autolus Therapeutics Plc's next earnings date is March 19, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
